Epstein Secrets

tlev Engel Klaus Engel Richard P. Eno David R. Epstein Mary Callahan Erdoes Charles W. Ergen Paula E

kil Beshir Ulrich L. Bettermann Erik Behermann Jeffrey L. Bewkes Donald S. Beyer Homi K. Bhabha Neera

herine M. Gehl Horst F. Geicke Jurgen M. Geissinger Paul Geitner Bekele Geleta Richard L. Gelfond Eli Gelman Pierre Gentin William W. George Julie Louise Gerberding David R. Gergen Valery Gergiev Valerie Germain Nataliya Germanova Tillman U. Gerngross Olaf Gersemann Minelik Getahun Aart J. Geu

Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland

rman of the Board OBO Bettermann Group Germany Jeffrey L. Bewkes Chairman and Chief Executive Officer

rre Gentin Managing Director, Legal and Risk Credit Suisse USA William W. George Professor of Management Practice Harvard Business School USA Julie Louise Gerberding President, Merck Vaccines Merck & Co. Inc. USA David R. Gergen Director, Center for Public Leadership Harvard Kennedy School USA V

Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland

rman of the Board OBO Bettermann Group Germany Jeffrey L. Bewkes Chairman and Chief Executive Officer

rre Gentin Managing Director, Legal and Risk Credit Suisse USA William W. George Professor of Management Practice Harvard Business School USA Julie Louise Gerberding President, Merck Vaccines Merck & Co. Inc. USA David R. Gergen Director, Center for Public Leadership Harvard Kennedy School USA V

John K. Defterios John J. DeGioia Alain Dehaze Jeffrey Deitch Marijn E. Dekkers Michael S. Dell Chris

USA USA Germany Switzerland USA USA World Economic Forum Annual Meeting EFTA_R1_02105175 EFTA02707407 President, Merck Vaccines MSD USA Julie Louise Gerberding Mikhail Gerchuk Mohammad Abdullah Al Gergawi David R. Gergen Valery Gergiev Natalia Germanova Olaf Gersemann Alan Gershenhorn Mi